DIN 02296489 — ADVAGRAF 5 MG
ADVAGRAF is a capsule (extended-release) of Tacrolimus marketed by ASTELLAS PHARMA CANADA INC. The full Tacrolimus monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02296489
- Brand name
- ADVAGRAF
- Active ingredient
- Tacrolimus
- Strength
- 5 MG
- Dosage form
- CAPSULE (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- ASTELLAS PHARMA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Calcineurin-inhibitor immunosuppressant
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Tacrolimus products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02454068 | ACH-TACROLIMUS | 0.5 MG | CAPSULE (IMMEDIATE-RELEASE) | ACCORD HEALTHCARE INC | MARKETED |
| 02456095 | ACH-TACROLIMUS | 1 MG | CAPSULE (IMMEDIATE-RELEASE) | ACCORD HEALTHCARE INC | MARKETED |
| 02456109 | ACH-TACROLIMUS | 5 MG | CAPSULE (IMMEDIATE-RELEASE) | ACCORD HEALTHCARE INC | MARKETED |
| 02296462 | ADVAGRAF | 0.5 MG | CAPSULE (EXTENDED-RELEASE) | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02296470 | ADVAGRAF | 1 MG | CAPSULE (EXTENDED-RELEASE) | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02331667 | ADVAGRAF | 3 MG | CAPSULE (EXTENDED-RELEASE) | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02243144 | PROGRAF | 0.5 MG | CAPSULE | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02175991 | PROGRAF | 1 MG | CAPSULE | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02175983 | PROGRAF | 5 MG | CAPSULE | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02176009 | PROGRAF | 5 MG | SOLUTION | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02416816 | SANDOZ TACROLIMUS | 0.5 MG | CAPSULE (IMMEDIATE-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02416824 | SANDOZ TACROLIMUS | 1 MG | CAPSULE (IMMEDIATE-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02416832 | SANDOZ TACROLIMUS | 5 MG | CAPSULE (IMMEDIATE-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02528592 | SANDOZ TACROLIMUS XR | 0.5 MG | CAPSULE (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02528606 | SANDOZ TACROLIMUS XR | 1 MG | CAPSULE (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02528622 | SANDOZ TACROLIMUS XR | 3 MG | CAPSULE (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02528630 | SANDOZ TACROLIMUS XR | 5 MG | CAPSULE (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |